As of 4/1/24, the iTracker 2.0 app will no longer be supported by Teva.COP-46886 4/24

For NEW Patient Copay Assistance information, please click on this link


COPAXONE® (glatiramer acetate injection) is used to treat relapsing forms of multiple sclerosis (MS). It is a subcutaneous injection made with a nonpyrogenic solution, 20 mg or 40 mg of glatiramer acetate, and 40 mg of the inactive ingredient mannitol.1

Couple looking up information for COPAXONE®.


Clinical results for COPAXONE®.

Learn about the results
Christine Boutwell, MD talking to a patient about COPAXONE®.

Side Effects of COPAXONE®

Find answers about possible side effects, symptoms, and other frequently asked questions about treatment.

Get the facts
COPAXONE® (glatiramer acetate injection) 40 mg packaging.

Dosing for COPAXONE®

Helpful information to know when talking to your doctor about starting—or switching to—COPAXONE® 40 mg and where to turn for assistance at any time.

Fit your routine


  1. COPAXONE® (glatiramer acetate injection) Current Prescribing Information Parsippany, NJ. Teva Neuroscience, Inc.

You are about to leave and enter a website operated by a third party.

Would you like to continue?

The information on this site is intended for healthcare professionals in the United States. Are you a healthcare professional in the United States?